BACKGROUND: IGF-1 is a potent mitogen for vascular smooth muscle cells, but exerts protective effects on endothelial cells that may trigger antiatherogenic mechanisms. OBJECTIVES: This study was designed to test the hypothesis that an IGF-1 excess following arterial injury prevents neointima formation and vascular stenosis. METHODS: Rats were subjected to carotid balloon injury and treated with IGF-1 (1.2 mg kg(-1) per die) or saline for 10 days. RESULTS: In IGF-1 treated animals, high tissue levels of eNOS, Akt and its phosphorylated form were found, confirming activation of IGF-1-dependent signaling pathways. IGF-1 markedly reduced neointima formation and post-injury arterial stenosis. IGF-1 exerted proliferative and anti-apoptotic effects in the media of injured carotids, but inhibited mitotic activity and induced apoptosis in the neointima. Furthermore, IGF-1 stimulated mobilization of progenitor endothelial cells and re-endothelialization of the injured arteries. L-NAME administration inhibited IGF-1 vasculoprotective effects. CONCLUSIONS: IGF-1 attenuates post-injury carotid stenosis by exerting differential effects in the neointima and tunica media with regard to the key components of the response to injury. The data point to a novel role of IGF-1 as a potent vasculoprotective factor.
BACKGROUND:IGF-1 is a potent mitogen for vascular smooth muscle cells, but exerts protective effects on endothelial cells that may trigger antiatherogenic mechanisms. OBJECTIVES: This study was designed to test the hypothesis that an IGF-1excess following arterial injury prevents neointima formation and vascular stenosis. METHODS:Rats were subjected to carotid balloon injury and treated with IGF-1 (1.2 mg kg(-1) per die) or saline for 10 days. RESULTS: In IGF-1 treated animals, high tissue levels of eNOS, Akt and its phosphorylated form were found, confirming activation of IGF-1-dependent signaling pathways. IGF-1 markedly reduced neointima formation and post-injury arterial stenosis. IGF-1 exerted proliferative and anti-apoptotic effects in the media of injured carotids, but inhibited mitotic activity and induced apoptosis in the neointima. Furthermore, IGF-1 stimulated mobilization of progenitor endothelial cells and re-endothelialization of the injured arteries. L-NAME administration inhibited IGF-1 vasculoprotective effects. CONCLUSIONS:IGF-1attenuates post-injury carotid stenosis by exerting differential effects in the neointima and tunica media with regard to the key components of the response to injury. The data point to a novel role of IGF-1 as a potent vasculoprotective factor.
Authors: D Sorriento; A Fusco; M Ciccarelli; A Rungi; A Anastasio; A Carillo; G W Dorn; B Trimarco; G Iaccarino Journal: FEBS Lett Date: 2013-09-10 Impact factor: 4.124
Authors: D Sorriento; C Del Giudice; A Bertamino; M Ciccarelli; I Gomez-Monterrey; P Campiglia; E Novellino; M Illario; B Trimarco; N De Luca; G Iaccarino Journal: Br J Cancer Date: 2014-11-25 Impact factor: 7.640
Authors: William E Sonntag; Ferenc Deak; Nicole Ashpole; Peter Toth; Anna Csiszar; Willard Freeman; Zoltan Ungvari Journal: Front Aging Neurosci Date: 2013-07-02 Impact factor: 5.750
Authors: Chiara De Biase; Roberta De Rosa; Rossella Luciano; Stefania De Luca; Ernesto Capuano; Bruno Trimarco; Gennaro Galasso Journal: Front Physiol Date: 2014-02-03 Impact factor: 4.566
Authors: Antonio Bilancio; Barbara Rinaldi; Maria Antonietta Oliviero; Maria Donniacuo; Maria Gaia Monti; Amedeo Boscaino; Irene Marino; Lori Friedman; Francesco Rossi; Bart Vanhaesebroeck; Antimo Migliaccio Journal: Biosci Rep Date: 2017-09-27 Impact factor: 3.840